See the DrugPatentWatch profile for Neupogen
Which Neupogen biosimilars are on the market?
Neupogen is the brand name for filgrastim (a granulocyte colony-stimulating factor, or G-CSF). Biosimilars to Neupogen are listed under “filgrastim” in regulatory databases and drug-biosimilar lists.
I don’t have any provided source list of specific marketed Neupogen (filgrastim) biosimilars in the information you supplied, so I can’t reliably name the exact products available in your country.
What biosimilar list should I check (and what wording to use)?
Search using these terms, which match how regulators typically list products:
- “filgrastim biosimilar”
- “G-CSF biosimilar (filgrastim)”
- “Neupogen biosimilar (filgrastim-something)”
If you tell me your country, I can produce the exact list
Biosimilar availability depends on the country (and sometimes the specific formulation and strength). If you share your country (for example, US, EU, UK, Canada, India), I can compile the marketed filgrastim biosimilars that correspond to Neupogen in that jurisdiction.
Is Neupogen the same as other filgrastim products?
Many “Neupogen biosimilar” queries also include related G-CSF brands and long-acting versions (like pegfilgrastim), but those are different molecules. To keep the list accurate, the key is biosimilars to filgrastim specifically (not pegfilgrastim).
---
Tell me the country you want (and whether you mean “filgrastim” only, not pegfilgrastim), and I’ll return the exact Neupogen (filgrastim) biosimilar product list for that market.